publication . Other literature type . 2021

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang; Fabian Schmidt; Yiska Weisblum; Frauke Muecksch; Christopher O. Barnes; Shlomo Finkin; Dennis Schaefer-Babajew; Melissa Cipolla; Christian Gaebler; Jenna A. Lieberman; ...
Open Access
  • Published: 19 Jan 2021
  • Publisher: Cold Spring Harbor Laboratory
<jats:p>To date severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 100 million individuals resulting in over two million deaths. Many vaccines are being deployed to prevent coronavirus disease 2019 (COVID-19) including two novel mRNA-based vaccines<jats:sup>1,2</jats:sup>. These vaccines elicit neutralizing antibodies and appear to be safe and effective, but the precise nature of the elicited antibodies is not known<jats:sup>3–6</jats:sup>. Here we report on the antibody and memory B cell responses in a cohort of 20 volunteers who received either the Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) vaccines. Consistent with prior rep...
Persistent Identifiers
free text keywords: Vesicular stomatitis virus, biology.organism_classification, biology, Memory B cell, Antibody, biology.protein, Monoclonal antibody, medicine.drug_class, medicine, Epitope, Coronavirus, medicine.disease_cause, Recombinant DNA, law.invention, law, Virology, Neutralization
Any information missing or wrong?Report an Issue